MUCH SHORTER EXPOSURE— #B117 is so infectious—very short exposure can lead to #COVID19. Many infected via just a few minutes inside a store. 🇨🇦 local health dept has shortened the exposure time to as little as ***1 second if not wearing face masks**. 🧵 theglobeandmail.com/canada/article…
2) spokeswoman for Ontario Health Minister Christine Elliott said on Sunday that the government has provided interim guidance to the province’s public-health units for screening and tracing contacts of cases associated with COVID-19 variants of concern.
3) “This guidance does include a lower threshold for classifying contacts as high risk of exposure and requiring quarantine,”
4) Contact tracers in York Region are finding that some individuals who have tested positive for the highly contagious variant have been in a retail store for just a few minutes. ⚠️
5) “Right now, we’re struggling to get to each person within 24 hours,” Dr. Lee told reporters on Friday. “I honestly believe that we are going to be continuing to be overwhelmed with more and more cases.”
6) Meanwhile in UK, #B117 has taken over the country’s cases. Literally. Just that more infectious than the old.
10) I want to take a moment to contextualize — it’s not that we ever thought <15 minutes of contact within 6 feet was safe & 15:01 was not, but that we had to create an arbitrary gradient for reasonable definition for close contact for the original virus, to capture highest risk.
11) And it was to make contact tracing & quarantining manageable scale. But we have known for a while that the 6 feet (2 meter) rule is not very meaningful if there is aerosol transmission, especially indoors with poor ventilation. The coronavirus is very much airborne folks.
12) And thus, the 6 feet rule should have been taken out / guidelines updated long ago for indoor transmission and definition of close contacts. And that was to a degree a failure of leaders to acknowledge and act on that, in the name of managing contact tracing.
13) At this point, with more infectious #B117 variant, it is high time we recognize a new definition of close contact, depending on: masking, indoor/outdoor, time if indoors, ventilation indoors; distance outdoors—and then assign gradients on red, orange, yellow close contacts.
14) And then take precautions for each type of red/orange/yellow “close contacts”. Trace certain ones quicker, quarantine certain ones longer & more aggressively, tests certain ones more repeatedly, and require greater monitoring for the first degree “redder” contacts.
15) As for schools, we DEFINITELY need kids to mask if we reopen. Kids, even if less susceptible than adults, do transmit (@dgurdasani1 and I have entire long long 🧵s on this) and transmit more. And as an epidemiologist, I cannot endorse indoor cafeterias. Outdoor tents please.
16) Wedding dinner parties (god forbid) should avoid indoor events too. So crowded school cafeterias cannot be possibly safe — I have seen ZERO evidence or arguments how cafeterias can be safe without major overhaul. Why can’t we construct / assemble more outdoor tents meantime?
17) And yes, outdoor tents cost money, but they cannot be THAT much more to acquire—and cities/states/federal govt should fund them. If it means we can reopen schools — with outdoor (well ventilated) tents for lunch cafeteria— I’m sure there is a way if we can then open schools.
18) Like every parent with young kids can understand—getting kids back is school is of paramount importance. We can mitigate risk in classrooms with HEPA filters, masks, & maybe safe UV HVAC upgrades if we can afford—but SCHOOL CAFETERIAS we likely can’t without outdoor tents ⛺️!
19) And for those who say “just send kids to school for half days without cafeteria lunches or classroom lunches”—that’s not enough schooling for kids for just half day. I1st-12th graders cannot do half days like kindergarteners and get enough education. We need real solutions.
20) Thus, going forward—We should demand to see real solutions in school reopening plans to address LUNCHROOM SAFETY. Kids can’t mask while eating lunch, and you can’t do no-mask indoors. Either uber-ventilate/disinfect cafeterias or just MOVE LUNCHES OUTDOORS’
21) Another idea if we have school indoor cafeterias, is to either install upper air UV (used in many restaurants that circulates air to ceiling where UV lights are safely pointed), or bring a pair of huge air flow tubes to outside that ventilated the cafeteria at high speed.
22) I also like the idea of summer schools with outdoor learning. Also, more people vaccinated by summer too. But cafeteria / lunchroom dining safety still key.
23) When you watch the SuperBowl this weekend, remember the season was saved because the NFL knew the 15 minutes + 6 ft rule was wrong. The coronavirus gospel of ‘within six feet for more than 15 minutes’ wasn’t enough—and the NFL had the data to prove it. wsj.com/articles/super…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
📍 THE 17 FIRED MEMBERS OF CDC’s VACCINE ADVISORY COMMITTEE (ACIP) speak out…
📍“As former ACIP members, we are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people’s access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses.” 🔥
Full text:
Vaccines are one of the greatest global public health achievements. Vaccine recommendations have been critical to the global eradication of smallpox and the elimination of polio, measles, rubella, and congenital rubella syndrome in the US. They have also dramatically decreased cases of hepatitis, meningitis, mumps, pertussis (whooping cough), pneumonia, tetanus, and varicella (chickenpox), and prevented cancers caused by hepatitis B virus and human papillomaviruses.1 Recent scientific advancements enabled the accelerated development, production, and evaluation of COVID-19 vaccines, leveraging novel technologies that are estimated to have prevented approximately 1.6 million hospitalizations and 235 000 deaths in the US alone.2
For more than 60 years, the Advisory Committee on Immunization Practices (ACIP)—codified in the federal regulations (42 USC 217a: advisory councils or committees)—has served as a panel of experts that reviews the most up-to-date evidence on vaccines and monoclonal antibodies (eg, against respiratory syncytial virus [RSV]), providing sound recommendations to the US Centers for Disease Control and Prevention (CDC) regarding how vaccines should be used. ACIP recommendations are the cornerstone of the immunization program in this country. First, they serve as guidance and are the national standard for the use of Food and Drug Administration (FDA) authorized and licensed vaccines, providing a unified and trusted approach to vaccinations for the diverse array of immunization providers across the US. Second, they ensure science-based and tested immunization schedules that are optimized for well-timed protection against serious diseases. Third, the recommendations affect insurance coverage and safeguard broad access for vaccines. Fourth, ACIP’s continued monitoring of disease epidemiology and scrutiny of vaccine safety inform timely updates to recommendations that have maintained the trust and protection of the population. This transparent and ongoing surveillance of vaccines is one of the most stringent around the world, historically making the deliberations and decisions of this committee a beacon for immunization programs globally, while also serving as the foundation for recommendations harmonized with leading medical organizations in the US.3,4
ACIP committee members have always been selected through a rigorous process based on their expertise in immunology, epidemiology, pediatrics, obstetrics, internal and family medicine, geriatrics, infectious diseases, and public health. Historically, committee members were chosen because they worked at hospitals, clinics, health departments, universities, and other organizations where they dedicated themselves to caring for patients, conducting research, and helping to prevent and treat infectious diseases. Members’ deep understanding of immunization issues ensured that vaccine policies were grounded in scientific evidence, aligned with the needs of economically, socially, and medically diverse US communities, and always considered the public value, trust, and acceptability of vaccines.
Despite recent suggestions to the contrary, health care providers and the US public trust ACIP. For the past 18 years, the National Immunization Survey has shown that 99 of every 100 children in the US have received at least some recommended vaccines by 2 years of age, consistent with acceptance of ACIP recommendations implemented by trusted clinicians (National Immunization Survey - Childof Healthy People 2030).…
2) Full text part 2:
This does not suggest the population is so distrustful that it warrants dismantling the process by which vaccines have been recommended. ACIP standard procedures have minimized the risk of alleged conflicts of interest and biases. For decades, members of ACIP have undergone a thorough application and review process to participate. Proposed members submitted letters of support from other known experts and peers, completed an interview process, underwent a background check, and disclosed financial interests that might be considered a conflict, including any professional or financial relationships of immediate family members. Historically, it has taken up to 2 years for nominees to be approved to join ACIP.
Once part of the committee, ACIP members spent significant time preparing for meetings, reviewing the scientific evidence, and chairing work groups that, along with many CDC public health officials, led to the final recommendations that were determined during public meetings, which also included opportunities for public comment. Recordings of these meetings, agendas, and presentations were publicly available. Additionally, members agreed to ongoing monitoring and disclosure throughout their tenure. For example, potential conflicts of interest were reviewed throughout their time on the committee. Statements about potential conflicts were required during each meeting and before each vote, and members recused themselves from voting if any conflicts were identified. These disclosures have also recently been posted on the CDC website for public scrutiny. ACIP was among the most stringent and transparent of the federal committees, and we hope those criteria will apply to any new members joining the committee.
The abrupt dismissal of the entire membership of the ACIP, along with its executive secretary, on June 9, 2025, the appointment of 8 new ACIP members just 2 days later, and the recent reduction of CDC staff dedicated to immunizations have left the US vaccine program critically weakened.5,6 These actions have stripped the program of the institutional knowledge and continuity that have been essential to its success over decades. Notably, the ACIP charter specifies that committee members serve overlapping terms to ensure continuity and avoid precisely the disruption that will now ensue. The termination of all members and its leadership in a single action undermines the committee’s capacity to operate effectively and efficiently, aside from raising questions about competence.
Compounding these concerns, recent changes to COVID-19 vaccine policy, made directly by the HHS secretary and released on social media, appear to have bypassed the standard, transparent, and evidence-based review process.7 Such actions reflect a troubling disregard for the scientific integrity that has historically guided US immunization strategy. The newly stated strategy to replace ACIP members with individuals who will “exercise independent judgment, refuse to serve as a rubber stamp, and foster a culture of critical inquiry” is already leading to warnings by academic and scientific institutions, professional organizations, and the public who for decades have known well that these sought-after qualities precisely characterized the now-dismissed members of the ACIP.5
3) Part 3:
As former ACIP members, we are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people’s access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses. Vaccines and the anti-RSV monoclonal antibodies are lifesaving, and people in the US deserve to have recommendations and broad access to use them to prevent serious diseases. In this age of government efficiency, the US public needs to know that the routine vaccination of approximately 117 million children from 1994-2023 likely prevented around 508 million lifetime cases of illness, 32 million hospitalizations, and 1 129 000 deaths, at a net savings of $540 billion in direct costs and $2.7 trillion in societal costs.8Finally, as individuals, we remain committed to evidence-based vaccine policy, both through our ongoing work in immunization science, public health, and medical education, and by supporting future efforts to keep America healthy that uphold scientific rigor and the public’s trust.
We might soon see the Trump WH impose tariffs on pharmaceuticals—patients will suffer and die.
During the past few weeks, President Trump’s on-again, off-again tariff wars have rattled the stock market, decimated many Americans’ retirement funds, and promised to send grocery prices soaring—and his administration hasn’t even gotten to critical pharmaceutical tariffs yet. But that will likely be the next shoe to drop.
Trump exempted pharmaceuticals from his first round of tariffs in early April, but recently declared that he intends to impose “a major tariff” on imported medicines “very shortly.” These tariffs, he claims, will prompt pharmaceutical companies to leave countries including China and India and begin “opening up their plants all over the place.”
Commerce Secretary Howard Lutnick said in a television interview in mid-April that these tariffs are coming in the “next month or two.”
2) The majority of brand name drugs used in the United States are imported. Even generic drugs often rely on ingredients and direct imports from China, including pain relievers and cardiovascular drugs used by millions.
3) The United States was already facing a drug shortage crisis before Trump’s tariff announcement. Now, his policies will drive upnot only the cost of medicines, but also other health care items such as X-ray machines and medical instruments.
It’s a trap: CATCH 22—if you register, ICE will deport you. If you don’t register, you’ve now committed a crime for the first time, and ICE will deport you. Trump doesn’t care if you’ve paid all taxes and followed all laws—ICE will deport you.
2) The Department of Homeland Security announced that it was mandating that all people in the United States illegally register with the federal government, and said those who didn’t self-report could face fines or prosecution. ***Failure to register is considered a crime***
3) Registration will be mandatory for everyone 14 and older without legal status. People registering have to provide their fingerprints and address, and parents and guardians of anyone under age 14 must ensure they registered. The registration process also applies to Canadians who are in the U.S. for more than 30 days, such as so-called snowbirds who spend winter months in places like Florida.
3) “Kennedy is set to announce Thursday the planned changes, which include axing 10,000 full-time employees spread across departments tasked with responding to disease outbreaks, approving new drugs, providing insurance for the poorest Americans and more”.